GenScript Launches Peptide Array Service

April 27, 2010 - PRLog -- -Internationally recognized biology contract research organization GenScript USA Inc. recently launched peptide array service, which is designed for quick and cost-effective peptide screening applications.  

GenScript’s peptide array service utilizes SPOT technology, which serves as a powerful proteomic technique to study molecular recognition events and identify biologically active peptides. With automated instrumentation, GenScript is able to quickly and cost-effectively synthesize a large number of addressable peptides in small amounts on special cellulose membranes. It can be used for applications that involve peptide screening, such as epitope mapping, protein-protein, enzyme-substrate, and receptor-ligand interactions studies, phosphorylation studies, as well as binding and functional assay studies.

http://www.genscript.com/peptide_array.html

The service features flexible delivery choices, both membrane-bound peptides and cleaved peptides from membrane in lyophilized format can be delivered for researchers’ different applications. In particular, membrane-bound peptide array allows in situ screening of peptide arrays due to the special properties of the membrane supports.  

GenScript is a contract research organization (CRO) specialized in biological research and drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript has become a world-leading Biology CRO and the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.